WilmerHale Named Biotechnology and Life Sciences Firm of the Year and Recognized in 2026 “Best Law Firms” Directory

WilmerHale Named Biotechnology and Life Sciences Firm of the Year and Recognized in 2026 “Best Law Firms” Directory

Recognition

WilmerHale has been recognized as the “Biotechnology and Life Sciences Practice Law Firm of the Year” by Best Lawyers in the Best Law Firms directory. Each year, only one law firm is selected for this distinction in each legal practice area represented in the directory. WilmerHale’s Life Sciences Practice brings together extensive industry experience and multidisciplinary legal acumen to assist clients with complex transactions, regulatory matters, and high-stakes litigation. For more than forty years, the firm has collaborated with prominent biotechnology, pharmaceutical, and medical device companies across the globe to safeguard innovation and support growth. 

WilmerHale has been named one of the nation's top law firms by Best Lawyers for 16 years in a row, earning first-tier rankings in 25 national and 75 metro-area practice areas. These honors are based on thorough client feedback and peer reviews from leading attorneys. 

WilmerHale has been recognized with national first-tier rankings in the following categories: 

Antitrust Law 
Appellate Practice 
Bankruptcy and Creditor Debtor Rights / Insolvency and Reorganization Law 
Biotechnology and Life Sciences Practice 
Commercial Litigation 
Copyright Law 
Corporate Law 
Criminal Defense: White-Collar 
Environmental Law 
International Arbitration - Commercial 
International Arbitration - Governmental 
Litigation - Antitrust 
Litigation - Bankruptcy 
Litigation - Intellectual Property 
Litigation - Patent 
Litigation - Regulatory Enforcement (SEC, Telecom, Energy) 
Litigation - Securities 
Mergers and Acquisitions Law 
Mutual Funds Law 
Patent Law 
Securities / Capital Markets Law 
Securities Regulation 
Tax Law 
Trademark Law 
Venture Capital Law

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.